메뉴 건너뛰기




Volumn 100, Issue 3, 2006, Pages 449-450

Predicting "unresectable" ovarian cancer: Taking aim at a moving target

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN;

EID: 32644471714     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.01.005     Document Type: Editorial
Times cited : (19)

References (18)
  • 1
    • 0016586897 scopus 로고
    • Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
    • C.T. Griffiths Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma Natl. Cancer Inst. Monogr. 42 1975 101 104
    • (1975) Natl. Cancer Inst. Monogr. , vol.42 , pp. 101-104
    • Griffiths, C.T.1
  • 3
    • 0028237380 scopus 로고
    • The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
    • W.J. Hoskins, W.P. McGuire, M.F. Brady, H.D. Homesley, W.T. Creasman, and M. Berman The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma Am. J. Obstet. Gynecol. 170 1994 974 979
    • (1994) Am. J. Obstet. Gynecol. , vol.170 , pp. 974-979
    • Hoskins, W.J.1    McGuire, W.P.2    Brady, M.F.3    Homesley, H.D.4    Creasman, W.T.5    Berman, M.6
  • 5
    • 0028952438 scopus 로고
    • The effect of debulking surgery after induction chemotherapy on the prognosis I advanced epithelial ovarian cancer
    • M.E.L. van der Burg, M. van Lent, M. Buyse, A. Kobierska, N. Colombo, and G. Favalli The effect of debulking surgery after induction chemotherapy on the prognosis I advanced epithelial ovarian cancer N. Engl. J. Med. 332 1995 629 634
    • (1995) N. Engl. J. Med. , vol.332 , pp. 629-634
    • Van Der Burg, M.E.L.1    Van Lent, M.2    Buyse, M.3    Kobierska, A.4    Colombo, N.5    Favalli, G.6
  • 8
    • 0034111537 scopus 로고    scopus 로고
    • The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma
    • D.S. Chi, E.S. Venktraman, V. Masson, and W.J. Hoskins The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma Gynecol. Oncol. 77 2000 227 231
    • (2000) Gynecol. Oncol. , vol.77 , pp. 227-231
    • Chi, D.S.1    Venktraman, E.S.2    Masson, V.3    Hoskins, W.J.4
  • 9
    • 0027394686 scopus 로고
    • Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian cancer
    • B.E. Nelson, A.T. Rosenfeld, and P.E. Schwartz Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian cancer J. Clin. Oncol. 11 1993 166 172
    • (1993) J. Clin. Oncol. , vol.11 , pp. 166-172
    • Nelson, B.E.1    Rosenfeld, A.T.2    Schwartz, P.E.3
  • 10
    • 0034307229 scopus 로고    scopus 로고
    • A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography
    • R.E. Bristow, L. Duska, N. Lambrou, E.K. Fishman, M.J. O'Neill, and E.L. Trimble A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography Cancer 89 2000 1532 1540
    • (2000) Cancer , vol.89 , pp. 1532-1540
    • Bristow, R.E.1    Duska, L.2    Lambrou, N.3    Fishman, E.K.4    O'Neill, M.J.5    Trimble, E.L.6
  • 11
    • 3042823262 scopus 로고    scopus 로고
    • The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma
    • S. Dowdy, S. Mullany, K. Brandt, B. Huppert, and W. Cliby The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma Cancer 101 2004 346 352
    • (2004) Cancer , vol.101 , pp. 346-352
    • Dowdy, S.1    Mullany, S.2    Brandt, K.3    Huppert, B.4    Cliby, W.5
  • 13
    • 0032422162 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: A retrospective analysis of 285 patients
    • I. Vergote, I. De Wever, W. Tjalma, M. Van Gramberen, J. Decloedt, and P. van Dam Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients Gynecol. Oncol. 71 1998 431 436
    • (1998) Gynecol. Oncol. , vol.71 , pp. 431-436
    • Vergote, I.1    De Wever, I.2    Tjalma, W.3    Van Gramberen, M.4    Decloedt, J.5    Van Dam, P.6
  • 14
    • 29144450706 scopus 로고    scopus 로고
    • Ovarian cancer surgical respectability: Relative impact of disease, patient status, and surgeon
    • G.D. Aletti, B.S. Gostout, K.C. Podratz, and W.A. Cliby Ovarian cancer surgical respectability: relative impact of disease, patient status, and surgeon Gynecol. Oncol. 100 2006 33 37
    • (2006) Gynecol. Oncol. , vol.100 , pp. 33-37
    • Aletti, G.D.1    Gostout, B.S.2    Podratz, K.C.3    Cliby, W.A.4
  • 16
    • 4444330066 scopus 로고    scopus 로고
    • Improved optimal cytoreduction rates for stage IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: A change in surgical approach
    • D.S. Chi, C.C. Franklin, D.A. Levine, F. Akselrod, P. Sabbatini, and W.R. Jarnagin Improved optimal cytoreduction rates for stage IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach Gynecol. Oncol. 94 2004 650 654
    • (2004) Gynecol. Oncol. , vol.94 , pp. 650-654
    • Chi, D.S.1    Franklin, C.C.2    Levine, D.A.3    Akselrod, F.4    Sabbatini, P.5    Jarnagin, W.R.6
  • 17
    • 0036141256 scopus 로고    scopus 로고
    • A population-based study of patterns of care for ovarian cancer: Who is seen by a gynecologic oncologist and who is not?
    • M.E. Carney, J.M. Lancaster, C. Ford, A. Tsodikov, and C.L. Wiggins A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? Gynecol. Oncol. 84 2002 36 42
    • (2002) Gynecol. Oncol. , vol.84 , pp. 36-42
    • Carney, M.E.1    Lancaster, J.M.2    Ford, C.3    Tsodikov, A.4    Wiggins, C.L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.